Lucigen Seeks to Market 'ExCyto' PCR Method to Amplify DNA from Transformed Bacteria | GenomeWeb

By Ben Butkus

In a research paper published this month, scientists from the University of Missouri and molecular biology firm Lucigen have for the first time described a method to amplify DNA transformed into bacterial cells that contain the polymerase needed to drive the reaction.

The technique, dubbed ExCyto PCR, may be a useful tool to increase the throughput, efficiency, and cost of routine nucleic acid amplification, or "dirty PCR," because there is no need to add exogenous enzyme, the researchers said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.